They found in both datasets that tumors with 11q deletion showed a higher proportion of CD8+ and resting CD4+ memory T cells, as well as of resting (M0) and polarized macrophages (M1 and M2) compared to neuroblastoma tumors without 11q deletion, the majority of which show MYCN amplification. The gene discussed is MYCN; the disease is neuroblastoma.